Brief report: immune checkpoint inhibitors use in lung cancer - a real-world outcome study in a middle-income country
Favorite
Share
More Options
6

Open in WPS to view all 6 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
